Wikidata

(Q43907336)

English

Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).

scientific article published in October 2013

In more languages

Statements

title
Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
author name string
Ahmet Kaya
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
Mustafa Kurt
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
Turgay Işik
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
Mehmet Ekinci
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
Yasemin Kaya
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
Selim Topçu
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
publication date
1 October 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017
page(s)
489-494
1 reference
stated in
Europe PubMed Central
PubMed ID
24283110
retrieved
27 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43907336&oldid=2104314431"